Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The United Laboratories International Holdings Limited and Novo Nordisk today announced topline results from a Chinese phase 2 trial of UBT251
-
Dr. Fabian Kausche, a distinguished animal health executive, joins ASTRA Therapeutics to strengthen strategic leadership and long-term value creation.
-
Vancouver, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- NEW EARTH RESOURCES CORP. (CSE: EATH) (“New Earth” or the “Company”) is pleased to provide an update on its ongoing exploration...
-
TRG Screen launches ROI calculator to help firms model cost savings, efficiency gains and risk reduction
-
Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business highlighting the significant progress it has made since closing its $100 million (£80 million)...
-
Press Release February, 24, 2026 Signify proposes changes to its Supervisory Board Proposal to appoint Barbara Holzapfel and Jeroen Hoencamp as Supervisory Board membersProposal to re-appoint...
-
Déclaration des transactions sur actions propres réalisées du 16 février au 20 février 2026 Puteaux, le 24 février 2026 Conformément à la réglementation relative aux rachats d’actions,...
-
Disclosure of trading in own shares occurred from February 16 to February 20, 2026 Puteaux, February 24, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU)...
-
Communiqué de presseNicox présente des données de Phase 3 positives confirmant le profil thérapeutique de NCX 470 lors du congrès annuel 2026 de l’American Glaucoma Society (AGS) 24 février 2026 –...
-
Press Release Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual MeetingFebruary 24, 2026 – release at 7:30 am CET Sophia...